TELA Bio, Inc. (TELA) Misses Q3 EPS by 3c

TELA Bio, Inc. (NASDAQ: TELA) reported Q3 EPS of ($0.19), $0.03 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $20.7 million versus the consensus estimate of $22.23 million.

For earnings history and earnings-related data on TELA Bio, Inc. (TELA) click here.

You May Also Be Interested In

• Senate votes to halt Iran war unless Trump gets approval from Congress
• Walmart to pay $1.4 billion for Vibe.co acquisition - WSJ
• Coherus and Zumutor to run Phase 1 trial combining ZM008 and Loqtorzi